ARCHIVES

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

This article is from The Cancer Letter archive.

Vol. 35 No. 31 | August 7, 2009

Download PDF Visit The Full Archive

Related Articles

Neutron Clinical Trials Contract Concept Approved

June 22, 1984

Rabson Recommended For NCI Acting Director, Will be Top Prospect For Permanent Appointment

August 26, 1988

20% of Women Do Not Believe Tailored Risk Assessments

August 30, 2013

No Proof Fiber Is Anticarcinogenic, Newell Says, But diet should Include Anyway

May 18, 1979

Intermittent Androgen Deprivation Therapy Not Equal to Continuous Treatment, Study Finds

April 26, 2013

Post Reporter Responds To Criticism Of Cancer Series

January 1, 1982